Oncotarget, Passing on Information to the Rest of the World

Oncotarget is a United States Oncology Journal created in 2010. For seven years, Oncotarget has been providing readers across the globe with the latest information dwelling on topics like Neuroscience, Pharmacology, Cardiology, Cell Biology, and Metabolism among many others. With Oncotarget being a free access journal, people interested in matters Oncology have found a reliable platform where they can read validated and well-researched information at no charge.

Since its inception, the journal has also prioritized information centering on cancer and aging. With Oncotarget being a highly sought after editorial, it now features on the SCImago Journal & Country Rank. Nationally, Oncotarget has taken the number 66 spot, a testament to the journal’s reliability. Since 2011, Oncotarget has been experiencing an upward trajectory in the number of views based on its size independent prestige indicator. Over the years, information from Oncotarget journals has become a reference point for many scholars across the globe, with 61% being the average number through which sources from the American Oncology editorial have gotten cited.

From 2011, the number of individuals citing sources from Oncotarget journals has increased by a large margin with the tally averaging 3700 sources annually. At the moment, Oncotarget has gained international acceptance because it has since day one provided valuable and relevant information to researchers and readers across the globe. Some of the notable journals that Oncotarget has created over time include CANcer-specific Evaluation System, Blockade of potassium ion transports enhances hypotonicity-induces cytocidal effects in gastric cancer, and Extracellular sphingomyelinase activity impairs TNF-a-induced endothelial cell death via ADAM17 activation and TNF receptor 1 shedding among many others.

Past and present statistics show that Oncotarget has been gaining fame annually, mainly because of providing a reliable platform for validated information. Through Oncotarget, people have since 2010 been in the know on what goes on in the healthcare world, with a proper emphasis getting placed on cancer and aging. To a large extent, Oncotarget has helped scientists advance their research and cures for particular diseases have gotten discovered in the process. Thus, Oncotarget has ultimately helped revolutionize global health standards.

To know more click here

 

 

Leave a Reply

Your email address will not be published. Required fields are marked *